Clinical Trial Update: A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 study of vismodegib in patients with advanced solid malignancies, including hepatocellular carcinoma, evaluating safety across varying renal/hepatic fun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-05-23